Get 20% lifetime commission for referring investors to digrin.com
here.
CorMedix Inc. (CRMD) Financials
CRMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 904.1 million | 443.2 million |
| March 31, 2026 | 815.6 million | 378.6 million |
| Dec. 31, 2025 | 826.1 million | 420.8 million |
| Sept. 30, 2025 | 750.9 million | 376.7 million |
CRMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 87.0 million | -4.6 million |
| March 31, 2026 | 41.7 million | 4.6 million |
| Dec. 31, 2025 | 92.7 million | 3.6 million |
| Sept. 30, 2025 | 30.4 million | 4.1 million |
CRMD Net Income
No data available :(
CRMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 256.7 million | 145.2 million | - |
| March 31, 2026 | 178.1 million | 144.9 million | - |
| Dec. 31, 2025 | 149.5 million | 144.6 million | 4.3 million |
| Sept. 30, 2025 | 55.7 million | 144.5 million | 4.4 million |
CRMD Shares Outstanding
CRMD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 729000 | 6.7 million | 27.5 million | 12.4 million |
| March 31, 2026 | 729000 | 7.2 million | 34.3 million | 12.5 million |
| Dec. 31, 2025 | 1.7 million | 8.6 million | 39.6 million | 16.0 million |
| Sept. 30, 2025 | 505774 | 5.1 million | 36.6 million | 11.2 million |
CRMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 101.9 million | 24.8 million |
| March 31, 2026 | 127.4 million | 22.3 million |
| Dec. 31, 2025 | 128.6 million | 21.3 million |
| Sept. 30, 2025 | 104.3 million | 11.2 million |
CRMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CRMD
Price: $7.67
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.18 USD
P/E Ratio: 3.46
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 278900
Market Capitalization: 587.7 million